Showing results (201-210 of 372) with videos related to
Sort By:
Pageof 38
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 13, 2012
Diagnostic performance of 18F-FET PET in newly diagnosed cerebral lesions suggestive of gliomaMarion Rapp, Alexander Heinzel, Norbert Galldiks, et al.Cancers|July 9, 2022
WNT/β-Catenin-Mediated Resistance to Glucose Deprivation in Glioblastoma Stem-like CellsSuad Yusuf, Philippe Aretz, Ann-Christin Nickel, et al.Journal of Cancer Research and Clinical Oncology|November 23, 2019
Bevacizumab versus alkylating chemotherapy in recurrent glioblastomaKatharina Seystahl, Bettina Hentschel, Sarah Loew, et al.Cancer Research|January 25, 2019
A DNA Repair and Cell-Cycle Gene Expression Signature in Primary and Recurrent Glioblastoma: Prognostic Value and Clinical ImplicationsMatthieu Gobin, Petr V Nazarov, Rolf Warta, et al.Neuro-Oncology Practice|July 19, 2021
Chemotherapy for adult patients with spinal cord gliomasDorothee Gramatzki, Jörg Felsberg, Bettina Hentschel, et al.Frontiers in Oncology|May 3, 2021
Radiomic Analysis to Predict Outcome in Recurrent Glioblastoma Based on Multi-Center MR Imaging From the Prospective DIRECTOR TrialAlex Vils, Marta Bogowicz, Stephanie Tanadini-Lang, et al.Matrix Biology : Journal of the International Society for Matrix Biology|February 26, 2011
SMOC1 is a tenascin-C interacting protein over-expressed in brain tumorsFlorence Brellier, Sabrina Ruggiero, Daniela Zwolanek, et al.Molecular Therapy. Oncology|July 6, 2026
Oncolytic virus-delivered GSDME: Unlocking pyroptosis to improve dendritic cell function and amplify cytotoxic T cell responseSabrina Schneider, Theresa Schwaiger, Joelle Kröll, et al.Brain : a Journal of Neurology|April 9, 2010
A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2 alphaSascha Seidel, Boyan K Garvalov, Valtteri Wirta, et al.Journal of Cancer Research and Clinical Oncology|August 5, 2020
Age-stratified clinical performance and survival of patients with IDH-wildtype glioblastoma homogeneously treated by radiotherapy with concomitant and maintenance temozolomideKerstin Berger, Bernd Turowski, Jörg Felsberg, et al.Pageof 38